Stock UniverseDerived research view · source repositories remain read-only

Anixa Biosciences, Inc. (ANIX)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
20.61
Global Rank
3276
Market Cap
99.47M
Latest Close
2.48
RS Composite
-35.35% · G#3135

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-18.95%
3M
-12.98%
6M
-48.87%
1Y
-11.11%
3Y
-18.95%
5Y
-37.53%
10Y
-23.46%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 109.98K · 30-day average: 111.73K · Max drawdown over stored range: -91.11%

Research Snapshot

Relative Strength vs SPX

RS Composite-35.35%
20D RS-16.85%
60D RS-24.62%
120D RS-55.33%
Global RS Rank3135 · 6.56% percentile
Watch+Speculative RS Rank1932 · 7.87% percentile
Group ScopeWatch+Speculative
Primary RS Rank393 · 14.19% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank437 / 701
Primary Percentile37.80
Score Notesmarket-cap support, industry-tailwind, microcap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for ANIX.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue0.51200.2100
Revenue Growth (YoY)2400%2400%2400%2400%2400%
Gross Profit0.12700.04900
Operating Income-13.136-13.875-11.011-13.831-11.701
Free Cash Flow-4.938-6.492-6.209-7.335-7.173
Free Cash Flow Per Share-0.173-0.214-0.2-0.23-0.221
EPS (Diluted) GAAP-0.453269-0.447586-0.316688-0.393566-0.336691
EPS Growth
EPS Non-GAAP
Gross Margin24.805%2400%23.333%2400%2400%
Operating Margin-2565.625%2400%-5243.333%2400%2400%
Profit Margin-2530.078%2400%-4671.905%2400%2400%
Free Cash Flow Margin-964.453%2400%-2956.667%2400%2400%
Shares Outstanding (Diluted)28.57930.37430.9831.89832.454
Shares Change (YoY)28.566%6.281%1.995%2.963%1.743%

SEC Quarterly Fundamentals

No processed quarterly rows for ANIX.